Back to results
US 2024/0390488 A1Published application
Methods of treating cancer using pd-1 axis binding antagonists and mek inhibitors
AssigneeGenentech, Inc.
InventorMelissa JUNTTILA
Life of this patent
Estimating the term…
Abstract
The present invention describes combination treatment comprising a PD-1 axis binding antagonist and a MEK inhibitor and methods for use thereof, including methods of treating conditions where enhanced immunogenicity is desired such as increasing tumor immunogenicity for the treatment of cancer.
Claims2
A method for treating or delaying progression of cancer in an individual comprising administering to the individual an effective amount of a PD-1 axis binding antagonist and a MEK inhibitor, wherein the individual has cancer or is at risk of developing cancer that is resistant to a B-raf antagonist.
2-53. (canceled)
Dependencies are inferred from the claim text.